Core Scientific's HPC and AI progress is overshadowed by investor concerns over its all-stock merger with CoreWeave.

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Amazon's Project Kuiper satellite launches have begun, with a target of offering consumer service in late 2025. Analyst ...

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...

Costco posted $26.44 billion in June sales, rising 8% YoY. BofA keeps Overweight rating, citing strong global growth and ...

For Ethereum staking, returns may range from 50% to 100% of the official protocol rate, due to the platform's method of ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $140.33, along ...

ARK Innovation ETF (BATS: ARKK) is pushing to fresh 52-week highs Thursday, buoyed by strong performances from its key ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

Shiba Inu (CRYPTO: SHIB) is showing strong signs of building momentum as burn activity spikes, large transactions increase, ...

iShares MSCI Brazil ETF EWZ -1.51% + Free Alerts fell 1.6% Thursday, adding to a 1.7% decline on Wednesday. The combined 3.3% ...

Autodesk shares are trading lower Thursday afternoon. The design software giant is reportedly exploring a potential ...